Vanguard Group
CORZ icon

Vanguard Group’s Core Scientific, Inc. Common Stock CORZ Stock Holding History

Vanguard Group’s Portfolio CORZ Stock Details CORZ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-12,275,463
Closed -$16M – 4573
2022
Q3 		$16M Buy
12,275,463
+8,251,891
+205% +$17.6M ﹤0.01% 2733
2022
Q2 		$6M Buy
4,023,572
+940,603
+31% +$4.32M ﹤0.01% 3275
2022
Q1 		$25.4M Buy
+3,082,969
New +$27.2M ﹤0.01% 2641

Other funds holding CORZ

Pathstone Family Office
Pathstone Family Office Englewood, New Jersey $13.1B AUM 20.8% 1-Year Est. Return
Mirae Asset Global Investments
Mirae Asset Global Investments Seoul, South Korea $67.7B AUM 57.61% 1-Year Est. Return
Comerica Bank
Comerica Bank Dallas, Texas $25.1B AUM 24.68% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Perigon Wealth Management
Perigon Wealth Management San Francisco, California $6.36B AUM 28.76% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return
Summit Trail Advisors
Summit Trail Advisors New York $7.95B AUM 26.49% 1-Year Est. Return
Group One Trading
Group One Trading Chicago, Illinois $71.1B AUM 128.96% 1-Year Est. Return
Coldstream Capital Management
Coldstream Capital Management Bellevue, Washington $7.99B AUM 24.2% 1-Year Est. Return
HRT Financial
HRT Financial New York $54.8B AUM 81.03% 1-Year Est. Return

Vanguard Group's CORZ Position: Q4 2022 in Review

Vanguard Group sold out of Core Scientific, Inc. Common Stock (CORZ) in Q4 2022, closing a stake of 12,275,463 shares — an estimated $16M sold.

Vanguard Group first reported a position in CORZ in Q1 2022 and held it in 3 quarters. The position peaked at $25.4M in Q1 2022. 90 funds tracked by Wall St. Rank hold CORZ as of Q4 2022.

  • Vanguard Group reported no remaining Core Scientific, Inc. Common Stock position as of Q4 2022 after selling out during the quarter.
  • Vanguard Group sold 12,275,463 Core Scientific, Inc. Common Stock shares in Q4 2022, an estimated $16M.
  • Vanguard Group first reported a position in Core Scientific, Inc. Common Stock in Q1 2022 and held it in 3 quarters.
  • Vanguard Group's Core Scientific, Inc. Common Stock position peaked at $25.4M in Q1 2022.
  • 90 funds tracked by Wall St. Rank held Core Scientific, Inc. Common Stock as of Q4 2022.

Based on Vanguard Group's 13F filing for Q4 2022, filed 10 Feb 2023.